This article was originally published in The Rose Sheet
After-tax impairment charge of $43 mil. will be taken in first quarter due to instability in Argentina and changes in accounting procedure, Dial Chief Financial Officer Rad Conrad says during Merrill Lynch conference March 19-20. Separately, Dial is presented with the Catalyst Blue Ribbon Board designation as one of 317 companies in the Fortune 1,000 with more than one female board member. Catalyst is a national organization for the advancement of women in business...
You may also be interested in...
This is an update of recommendations from the European Medicines Agency's Committee for Medicinal Products for Human Use on the authorization of new medicines in the European Union, and updates on EU marketing authorization changes recommended by the CHMP.
Sweden´s ecosystem for drug discovery and development is flourishing, seeded by academia, nurtured by incubators and funded from varied sources, 2020 report shows.
While Teva has helped to mitigate a Canadian shortage of salbutamol inhalers, Accord has struck a deal with the UK government to supply hydroxychloroquine. Sandoz is bolstering its inventory to meet demand and Apotex is donating critical medicines, while MedPharm’s new testing model will screen drugs for therapeutic eﬀectiveness and Beximco is focusing on manufacturing hydroxychloroquine, favipiravir and ivermectin.